Urotensin-II: More than a mediator for kidney

International Journal of Nephrology

Volumn 2012, Issue , 2012, Pages

  Balat, Ayşe ^a   Büyükçelik, Mithat ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84869023715     PISSN: 2090214X     EISSN: 20902158     Source Type: Journal    
DOI: 10.1155/2012/249790     Document Type: Review

References (63)

1. Pearson D., Shively J. E., Clark B. R., Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes. Proceedings of the National Academy of Sciences of the United States of America 1980 77 8 I 5021 5024 2-s2.0-0012963711 (Pubitemid 11236553)
2. Bern H. A., Pearson D., Larson B. A., Nishioka R. S., Neurohormones from fish tails: the caudal neurosecretory system - I. Urophysiology and the caudal neurosecretory system of fishes. Recent Progress in Hormone Research 1985 41 533 552 2-s2.0-0021776949
3. Totsune K., Takahashi K., Arihara Z., Sone M., Satoh F., Ito S., Kimura Y., Sasano H., Murakami O., Role of urotensin II in patients on dialysis. Lancet 2001 358 9284 810 811 2-s2.0-0035828410 10.1016/S0140-6736(01)06002-0 (Pubitemid 32868735)
4. Coulouarn Y., Lihrmann I., Jegou S., Anouar Y., Tostivint H., Beauvillain J. C., Conlon J. M., Bern H. A., Vaudry H., Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proceedings of the National Academy of Sciences of the United States of America 1998 95 26 15803 15808 2-s2.0-0032428160 10.1073/pnas.95.26.15803 (Pubitemid 29018781)
5. Ong K. L., Wong L. Y. F., Man Y. B., Leung R. Y. H., Song Y. Q., Lam K. S. L., Cheung B. M. Y., Haplotypes in the urotensin II gene and urotensin II receptor gene are associated with insulin resistance and impaired glucose tolerance. Peptides 2006 27 7 1659 1667 2-s2.0-33745070225 10.1016/j.peptides. 2006.02.008 (Pubitemid 43884768)
6. Ames R. S., Sarau H. M., Chambers J. K., Willette R. N., Alyar N. V., Romanic A. M., Louden C. S., Foley J. J., Sauermelch C. F., Coatney R. W., Ao Z., Disa J., Holmes S. D., Stadel J. M., Martin J. D., Liu W. S., Glover G. I., Wilson S., McNulty D. E., Ellis C. E., Elshourbagy N. A., Shabon U., Trill J. J., Hay D. W. P., Ohlstein E. H., Bergsma D. J., Douglas S. A., Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 1999 401 6750 282 286 2-s2.0-0033575930 10.1038/45809 (Pubitemid 29444282)
7. Liu Q., Pong S. S., Zeng Z., Zhang Q., Howard A. D., Williams D. L., Davidoff M., Wang R., Austin C. P., McDonald T. P., Bai C., George S. R., Evans J. F., Caskey C. T., Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14. Biochemical and Biophysical Research Communications 1999 266 1 174 178 2-s2.0-0033539884 10.1006/bbrc.1999.1796 (Pubitemid 30028787)
8. Gartlon J., Parker F., Harrison D. C., Douglas S. A., Ashmeade T. E., Riley G. J., Hughes Z. A., Taylor S. G., Munton R. P., Hagan J. J., Hunter J. A., Jones D. N. C., Central effects of urotensin-II following ICV administration in rats. Psychopharmacology 2001 155 4 426 433 2-s2.0-0034995607 10.1007/s002130100715 (Pubitemid 32523114)
9. Onan D., Hannan R. D., Thomas W. G., Urotensin II: the old kid in town. Trends in Endocrinology and Metabolism 2004 15 4 175 182 2-s2.0-1942453711 10.1016/j.tem.2004.03.007 (Pubitemid 38510498)
10. Maguire J. J., Kuc R. E., Davenport A. P., Orphan-receptor ligand human urotensin II: receptor localization human tissues and comparison of vasoconstrictor responses with endothelin-1. British Journal of Pharmacology 2000 131 3 441 446 2-s2.0-0033776533
11. Song W., Abdel-Razik A. E. S., Lu W., Ao Z., Johns D. G., Douglas S. A., Balment R. J., Ashton N., Urotensin II and renal function in the rat. Kidney International 2006 69 8 1360 1368 2-s2.0-33646123786 10.1038/sj.ki.5000290
12. Maguire J. J., Davenport A. P., Is urotensin-II the new endothelin? British Journal of Pharmacology 2002 137 5 579 588 2-s2.0-0036848062 10.1038/sj.bjp.0704924 (Pubitemid 35333083)
13. Maguire J. J., Kuc R. E., Wiley K. E., Kleinz M. J., Davenport A. P., Cellular distribution of immunoreactive urotensin-II in human tissues with evidence of increased expression in atherosclerosis and a greater constrictor response of small compared to large coronary arteries. Peptides 2004 25 10 1767 1774 2-s2.0-5144219967 10.1016/j.peptides.2004.01.028 (Pubitemid 39346219)
14. Bottrill F. E., Douglas S. A., Hiley C. R., White R., Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries. British Journal of Pharmacology 2000 130 8 1865 1870 2-s2.0-0033839169 (Pubitemid 30655798)
15. Qi J., Du J., Tang X., Li J., Wei B., Tang C., The upregulation of endothelial nitric oxide synthase and urotensin-II is associated with pulmonary hypertension and vascular diseases in rats produced by aortocaval shunting. Heart and Vessels 2004 19 2 81 88 2-s2.0-1842863447 10.1007/s00380-003-0739-3 (Pubitemid 38489035)
16. Affolter J., Webb D. J., Urotensin II: a new mediator in cardiopulmonary regulation? Lancet 2001 358 9284 774 775 2-s2.0-0035828413 10.1016/S0140- 6736(01)06005-6 (Pubitemid 32868720)
17. Lehner U., Velić A., Schröter R., Schlatter E., Sindić A., Ligands and signaling of the G-protein-coupled receptor GPR14, expressed in human kidney cells. Cellular Physiology and Biochemistry 2007 20 1-4 181 192 2-s2.0-34250768137 10.1159/000104165 (Pubitemid 46956823)
18. Proulx C. D., Holleran B. J., Lavigne P., Escher E., Guillemette G., Leduc R., Biological properties and functional determinants of the urotensin II receptor. Peptides 2008 29 5 691 699 2-s2.0-42049109932 10.1016/j.peptides.2007. 10.027
19. Elshourbagy N. A., Douglas S. A., Shabon U., Harrison S., Duddy G., Sechler J. L., Ao Z., Maleeff B. E., Naselsky D., Disa J., Aiyar N. V., Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey. British Journal of Pharmacology 2002 136 1 9 22 2-s2.0-0036261206 (Pubitemid 34499311)
20. Shenouda A., Douglas S. A., Ohlstein E. H., Giaid A., Localization of urotensin-II immunoreactivity in normal human kidneys and renal carcinoma. Journal of Histochemistry and Cytochemistry 2002 50 7 885 889 2-s2.0-0036065339 (Pubitemid 34774599)
21. Balat A., Karakök M., Yilmaz K., Kibar Y., Urotensin-II immunoreactivity in children with chronic glomerulonephritis. Renal Failure 2007 29 5 573 578 2-s2.0-34547151671 10.1080/08860220701392108 (Pubitemid 47123812)
22. Matsushita M., Shichiri M., Imai T., Iwashina M., Tanaka H., Takasu N., Hirata Y., Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues. Journal of Hypertension 2001 19 12 2185 2190 2-s2.0-0035208378 10.1097/00004872-200112000-00011 (Pubitemid 33135240)
23. Matsushita M., Shichiri M., Fukai N., Ozawa N., Yoshimoto T., Takasu N., Hirata Y., Urotensin II is an autocrine/paracrine growth factor for the porcine renal epithelial cell line, LLCPK1. Endocrinology 2003 144 5 1825 1831 2-s2.0-0038410059 10.1210/en.2003-0029 (Pubitemid 36543320)
24. Balat A., Pakir I. H., Gök F., Anarat R., Sahinoz S., Urotensin-II levels in children with minimal change nephrotic syndrome. Pediatric Nephrology 2005 20 1 42 45 2-s2.0-11244302450 10.1007/s00467-004-1716-5 (Pubitemid 40057852)
25. Mosenkis A., Danoff T. M., Aiyar N., Bazeley J., Townsend R. R., Human Urotensin II in the plasma of anephric subjects. Nephrology Dialysis Transplantation 2007 22 4 1269 1270 2-s2.0-34047102445 10.1093/ndt/gfl697 (Pubitemid 46523459)
26. Gardiner S. M., March J. E., Kemp P. A., Maguire J. J., Kuc R. E., Davenport A. P., Bennett T., Regional heterogeneity in the haemodynamic responses to urotensin II infusion in relation to UT receptor localisation. British Journal of Pharmacology 2006 147 6 612 621 2-s2.0-33645106688 10.1038/sj.bjp.0706503
27. Wilkinson I. B., Affolter J. T., De Haas S. L., Paola Pellegrini M., Boyd J., Winter M. J., Balment R. J., Webb D. J., High plasma concentrations of human urotensin II do not alter local or systemic hemodynamics in man. Cardiovascular Research 2002 53 2 341 347 2-s2.0-0036163976 10.1016/S0008- 6363(01)00485-0 (Pubitemid 34117684)
28. Böhm F., Pernow J., Urotensin II evokes potent vasoconstriction in humans in vivo. British Journal of Pharmacology 2002 135 1 25 27 2-s2.0-0036157935 (Pubitemid 34102094)
29. Nothacker H. P., Wang Z., McNeill A. M., Saito Y., Merten S., O'Dowd B., Duckles S. P., Civelli O., Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction. Nature Cell Biology 1999 1 6 383 385 2-s2.0-0033202995 (Pubitemid 129493582)
30. Charles C. J., Rademaker M. T., Richards A. M., Yandle T. G., Urotensin II: evidence for cardiac, hepatic and renal production. Peptides 2005 26 11 2211 2214 2-s2.0-27744438834 10.1016/j.peptides.2005.03.043 (Pubitemid 41584086)
31. Disa J., Floyd L. E., Edwards R. M., Douglas S. A., Aiyar N. V., Identification and characterization of binding sites for human urotensin-II in Sprague-Dawley rat renal medulla using quantitative receptor autoradiography. Peptides 2006 27 6 1532 1537 2-s2.0-33646758837 10.1016/j.peptides.2005.10.004 (Pubitemid 43766989)
32. Balat A., Urotensin-II in children with renal diseases: new messages from an ancient peptide. Salud i Ciencia 2007 15 6 961 965 2-s2.0-37249025668 (Pubitemid 350272763)
33. Loretz C. A., Bern H. A., Stimulation of sodium transport across the teleost urinary bladder by urotensin II. General and Comparative Endocrinology 1981 43 3 325 330 2-s2.0-0019510730 (Pubitemid 11159006)
34. Ovcharenko E., Abassi Z., Rubinstein I., Kaballa A., Hoffman A., Winaver J., Renal effects of human urotensin-II in rats with experimental congestive heart failure. Nephrology Dialysis Transplantation 2006 21 5 1205 1211 2-s2.0-33646173077 10.1093/ndt/gfk049
35. Zhang A. Y., Chen Y. F., Zhang D. X., Yi F. X., Qi J., Andrade-Gordon P., De Garavilla L., Li P. L., Zou A. P., Urotensin II is a nitric oxide-dependent vasodilator and natriuretic peptide in the rat kidney. American Journal of Physiology 2003 285 4 F792 F798 2-s2.0-0141590352 (Pubitemid 37140263)
36. Abdel-Razik A. E. S., Forty E. J., Balment R. J., Ashton N., Renal haemodynamic and tubular actions of urotensin II in the rat. Journal of Endocrinology 2008 198 3 617 624 2-s2.0-53349145908 10.1677/JOE-08-0260
37. Cheung B. M. Y., Leung R., Man Y. B., Wong L. Y. F., Plasma concentration of urotensin II is raised in hypertension. Journal of Hypertension 2004 22 7 1341 1344 2-s2.0-3042713965 10.1097/01.hjh.0000125452.28861.f1 (Pubitemid 38888080)
38. Russell F. D., Meyers D., Galbraith A. J., Bett N., Toth I., Kearns P., Molenaar P., Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure. American Journal of Physiology 2003 285 4 H1576 H1581 2-s2.0-0141788726 (Pubitemid 37169512)
39. Balat O., Aksoy F., Kutlar I., Ugur M. G., Iyikosker H., Balat A., Anarat R., Increased plasma levels of Urotensin-II in preeclampsia-eclampsia: a new mediator in pathogenesis? European Journal of Obstetrics Gynecology and Reproductive Biology 2005 120 1 33 38 2-s2.0-18144374156 10.1016/j.ejogrb.2004. 07.029 (Pubitemid 40615069)
40. Ravani P., Tripepi G., Pecchini P., Mallamaci F., Malberti F., Zoccali C., Urotensin II is an inverse predictor of death and fatal cardiovascular events in chronic kidney disease. Kidney International 2008 73 1 95 101 2-s2.0-37249064837 10.1038/sj.ki.5002565 (Pubitemid 350273632)
41. Abdel-Razik A. E. S., Balment R. J., Ashton N., Enhanced renal sensitivity of the spontaneously hypertensive rat to urotensin II. American Journal of Physiology 2008 295 4 F1239 F1247 2-s2.0-57049104060 10.1152/ajprenal.90374.2008
42. Eddy A. A., Barratt T. M., Avner E. D., Harmon W. E., Immune mechanisms of glomerular injury. Pediatric Nephrology 1999 4th Baltimore, Md, USA Lippincott Williams & Wilkins 641 668
43. Djordjevic T., BelAiba R. S., Bonello S., Pfeilschifter J., Hess J., Görlach A., Human urotensin II is a novel activator of NADPH oxidase in human pulmonary artery smooth muscle cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 3 519 525 2-s2.0-14644433774 10.1161/01.ATV.0000154279. 98244.eb (Pubitemid 40315672)
44. Tian L., Li C., Qi J., Fu P., Yu X., Li X., Cai L., Diabetes-induced upregulation of urotensin II and its receptor plays an important role in TGF- β 1-mediated renal fibrosis and dysfunction. American Journal of Physiology 2008 295 5 E1234 E1242 2-s2.0-57049159229 10.1152/ajpendo.90672.2008
45. Wang Y. X., Ding Y. J., Zhu Y. Z., Shi Y., Yao T., Zhu Y. C., Role of PKC in the novel synergistic action of urotensin II and angiotensin II and in urotensin II-induced vasoconstriction. American Journal of Physiology 2007 292 1 H348 H359 2-s2.0-33846188981 10.1152/ajpheart.00512.2006 (Pubitemid 46105197)
46. Lamarre N. S., Tallarida R. J., A quantitative study to assess synergistic interactions between urotensin II and angiotensin II. European Journal of Pharmacology 2008 586 1-3 350 351 2-s2.0-43549109808 10.1016/j.ejphar.2008.02.071
47. Rosen S., Crescentic glomerulonephritis. Occurrence, mechanisms and prognosis. Pathology Annual 1975 10 37 61
48. Cole B. R., Salinas-Madrigal L., Barratt T. M., Avner E. D., Harmon W. E., Acute proliferativeglomerulonephritis and crescentic glomerulonephritis. Pediatric Nephrology 1999 4th Baltimore, Md, USA Lippincott Williams & Wilkins 669 689
49. Sauzeau V., Le Mellionnec E., Bertoglio J., Scalbert E., Pacaud P., Loirand G., Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase. Circulation Research 2001 88 11 1102 1104 2-s2.0-0035827716 (Pubitemid 34132508)
50. Watanabe T., Pakala R., Katagiri T., Benedict C. R., Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells. Circulation 2001 104 1 16 18 2-s2.0-0035800017 (Pubitemid 32623283)
51. Tzanidis A., Hannan R. D., Thomas W. G., Onan D., Autelitano D. J., See F., Kelly D. J., Gilbert R. E., Krum H., Direct actions of Urotensin II on the heart: implications for cardiac fibrosis and hypertrophy. Circulation Research 2003 93 3 246 253 2-s2.0-0042525995 10.1161/01.RES.0000084382.64418.BC (Pubitemid 36993236)
52. Zhang Y. G., Li J., Li Y. G., Wei R. H., Urotensin II induces phenotypic differentiation, migration, and collagen synthesis of adventitial fibroblasts from rat aorta. Journal of Hypertension 2008 26 6 1119 1126 2-s2.0-43449112074 10.1097/HJH.0b013e3282fa1412 (Pubitemid 351670503)
53. Takahashi K., Totsune K., Kitamuro T., Sone M., Murakami O., Shibahara S., Three vasoactive peptides, endothelin-1, adrenomedullin and urotensin-II, in human tumour cell lines of different origin: expression and effects on proliferation. Clinical Science 2002 103 48, supplement 35S 38S 2-s2.0-0036672425 (Pubitemid 35007116)
54. Niaudet P., Barratt T. M., Avner E. D., Harmon W. E., Steroid-resistant idiopathic nephrotic syndrome. Pediatric Nephrology 1999 4th Baltimore, Md, USA Lippincott Williams & Wilkins 749 763
55. Takahashi K., Totsune K., Murakami O., Arihara Z., Noshiro T., Hayashi Y., Shibahara S., Expression of urotensin II and its receptor in adrenal tumors and stimulation of proliferation of cultured tumor cells by urotensin II. Peptides 2003 24 2 301 306 2-s2.0-0037302538 10.1016/S0196-9781(03)00039-1 (Pubitemid 36369351)
56. Bousette N., Patel L., Douglas S. A., Ohlstein E. H., Giaid A., Increased expression of urotensin II and its cognate receptor GPR14 in atherosclerotic lesions of the human aorta. Atherosclerosis 2004 176 1 117 123 2-s2.0-4043172801 10.1016/j.atherosclerosis.2004.03.023 (Pubitemid 39078653)
57. Makker S. P., Barratt T. M., Avner E. D., Harmon W. E., Membranous glomerulonephropathy. Pediatric Nephrology 1999 4th Baltimore, Md, USA Lippincott Williams & Wilkins
58. White R. H. R., Yoshikawa N., Feehally J J., Barratt T. M., Avner E. D., Harmon W. E., IgA nephropathy and Henoch-Schönlein nephritis. Pediatric Nephrology 1999 4th Baltimore, Md, USA Lippincott Williams & Wilkins 691 706
59. Balat A., Balci S. O., Buyukcelik M., Urotensin-II gene polymorphism in children with glomerular diseases: new messages from an ancient peptide? Proceedings of the World Congress of Nephrology Meeting (ERA '09) 2009 Milan, Italy
60. Sidharta P. N., Wagner F. D., Bohnemeier H., Jungnik A., Halabi A., Krähenbühl S., Chadha-Boreham H., Dingemanse J., Pharmacodynamics and pharmacokinetics of the urotensin II receptor antagonist palosuran in macroalbuminuric, diabetic patients. Clinical Pharmacology and Therapeutics 2006 80 3 246 256 2-s2.0-33748148272 10.1016/j.clpt.2006.05.013 (Pubitemid 44313907)
61. Clozel M., Hess P., Qiu C., Ding S. S., Rey M., The urotensin-II receptor antagonist palosuran improves pancreatic and renal function in diabetic rats. Journal of Pharmacology and Experimental Therapeutics 2006 316 3 1115 1121 2-s2.0-33644754588 10.1124/jpet.105.094821 (Pubitemid 43345285)
62. Sidharta P. N., Van Giersbergen P. L. M., Dingemanse J., Pharmacokinetics and pharmacodynamics of the urotensin-II receptor antagonist palosuran in healthy male subjects. Journal of Clinical Pharmacology 2009 49 10 1168 1175 2-s2.0-70349515824 10.1177/0091270009341181
63. Nitescu N., Grimberg E., Guron G., Urotensin-II receptor antagonism does not improve renal haemodynamics or function in rats with endotoxin-induced acute kidney injury. Clinical and Experimental Pharmacology and Physiology 2010 37 12 1170 1175 2-s2.0-78649752079 10.1111/j.1440-1681.2010.05449.x